The political economy of COVID-19 vaccination in Indonesia

被引:2
作者
Surianta, Andree [1 ]
Patunru, Arianto A. [2 ,3 ]
机构
[1] Australian Natl Univ, Canberra, ACT, Australia
[2] Australian Natl Univ, Coll Asia & Pacific, Crawford Sch Publ Policy, Arndt Corden Dept Econ, Canberra, ACT, Australia
[3] Australian Natl Univ, Coll Asia & Pacific, Crawford Sch Publ Policy, Arndt Corden Dept Econ, 9 Fellows Rd, Canberra, ACT 2601, Australia
关键词
COVID-19; Indonesia; inequity; policy; political economy;
D O I
10.1002/app5.381
中图分类号
K9 [地理];
学科分类号
0705 ;
摘要
The global COVID-19 vaccination has been marred by the problem of inequity. Low- and middle-income countries (LMICs), including Indonesia, must overcome global and local barriers to provide doses to their population. Due to a lack of domestic R&D capability, Indonesia relied on global vaccine producers that are subject to the whims of their own governments. Ensuring equitable access domestically was also a challenge as public sector resources were limited. Using the four dimensions of vaccine access to examine Indonesia & apos;s COVID-19 inoculation campaign reveals gaps in the government & apos;s perception of vaccination inequity. While the administration fervently advocates for global vaccination equity, local barriers received minimal attention. Indonesia & apos;s case highlights how domestic political dynamics can stymie a global effort and that resolving vaccination inequity requires lowering both global and local barriers. Finally, LMICs should also consider including private sector resources in their pandemic response to complement their limited public sector resources.
引用
收藏
页数:20
相关论文
共 64 条
[1]  
African Group, 2021, REVISED DECISION TEX
[2]  
[Anonymous], 2022, IDN FINANCIALS
[3]  
[Anonymous], 2023, ANTARA NEWS
[4]  
[Anonymous], 2021, Bangkok Post
[5]  
[Anonymous], Science Technology and innovation, Expenditure on RD, GERD by sector of performance, GERD performed by higher education (in 000 current PPP$)
[6]  
Aspinall E., 2022, MOST READ 2021 INDON
[7]  
Basyir H., 2020, PELUANG INDUSTRI VAK
[8]  
Bio F, 2022, BIOFARMA RECEIVE MRN
[9]  
Cabinet Secretariat of the Republic of Indonesia, 2021, SID MAJ UM KE 76 PBB
[10]  
Cabinet Secretariat of the Republic of Indonesia, 2022, GOVT KICK COVID 19 B